Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Condition(s):Metastatic Breast Cancer; End of LifeLast Updated:December 7, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Breast Cancer; End of LifeLast Updated:December 7, 2023Recruiting
Condition(s):Metastatic Breast CancerLast Updated:January 31, 2019Withdrawn
Condition(s):Metastatic Breast CancerLast Updated:April 7, 2023Active, not recruiting
Condition(s):Metastatic Breast CancerLast Updated:August 26, 2019Completed
Condition(s):Metastatic Breast CancerLast Updated:March 4, 2024Active, not recruiting
Condition(s):Metastatic Breast CancerLast Updated:June 5, 2023Not yet recruiting
Condition(s):Metastatic Breast CancerLast Updated:February 6, 2020Recruiting
Condition(s):HER2 Negative Metastatic Breast CancerLast Updated:April 14, 2016Completed
Condition(s):Metastatic Breast CancerLast Updated:December 3, 2009Completed
Condition(s):Metastatic Breast CancerLast Updated:August 22, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.